Q5119 Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg

Short descriptor: Inj ruxience, 10 mg

✓ Active HCPCS Level II 2026
Open Q5119 in the app →

Look up Q5119 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

Q5119 is the HCPCS Level II code for Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (2026). It belongs to Section Q — Temporary Codes. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Drugs.

Classification & CMS Attributes

Medicare Coverage
Carrier judgment (code C)
Part B Pricing
Drugs (indicator 51)
Type of Service
Medical care
Effective Date
2020-07-01
2026 Maintenance
No change this year

References

Cite This Page

Reference Q5119 with the canonical source and edition:

Q5119 — Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/Q5119

Canonical URL: https://icd10codingpro.com/hcpcs-codes/Q5119

Related Codes in Section Q

← Q5118 Inj., zirabev, 10 mg Q5120 → Inj pegfilgrastim-bmez 0.5mg
Q5115 Inj truxima 10 mg Q5116 Inj., trazimera, 10 mg Q5117 Inj., kanjinti, 10 mg Q5118 Inj., zirabev, 10 mg Q5120 Inj pegfilgrastim-bmez 0.5mg Q5121 Inj. avsola, 10 mg Q5122 Inj, nyvepria Q5123 Inj. riabni, 10 mg Q5124 Inj. byooviz, 0.1 mg Q5125 Inj, releuko 1 mcg
Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial